erythromycin

Key facts

INN

erythromycin

Brand

ILOTYCIN

Route

OPHTHALMIC

Formulation

TABLET

Originator

Amneal Pharmaceuticals

Related patents

patent

US 12370255

Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12365659

Non-polyamine based polyamine transport inhibitors and their use in the treatmen

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12343424

Photochemically stable, non-leaching, bridged polysilsesquioxane based sunscreen

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12311054

Compositions and methods of using propylene sulfide-based polymers for treatment

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12264366

Genome-based methods for reducing cardiovascular risk

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12233103

Indoleamine 2,3-dioxygenase based immunotherapy

Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12144877

Graphene-based multifunctional cosmetic compositions

Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 12133884

Methods of substituting pathogenic amino acids using programmable base editor sy

Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is erythromycin?

erythromycin (ILOTYCIN), is a pharmaceutical active ingredient, associated with Amneal Pharmaceuticals, with approved status in the US.

What is the brand name for erythromycin?

ILOTYCIN is a marketed brand name for erythromycin. Check FDA Drugs@FDA for the current US label holder.